000			01485nam a2200337 4500
003			NUST
005			20260520161518.0
008			260520b |||||||| |||| 00| 0 eng d
040			_aNUST _beng _cNUST _dNUST _erda
050			_aRC278.7.B7 TIZ
100			_aTizora, Phindile Mhlope. _eauthor.
245			_aPharmacogenetics of a standard tamoxifen therapy regimen in female breast cancer patients of black African origin in Zimbabwe / _cby Phindile Mhlope Tizora.
260			_aBulawayo, Zimbabwe : _bNational University of Science and Technology , _c©2019.
300			_axi, 105 pages : _billustrations ; _c30 cm.
336			_2rdacontent _atext _btxt
337			_2rdamedia _aunmediated _bn
338			_2rdacarrier _avolume _bnc
500			_aA thesis submitted in partial fulfilment of the requirements for the Master of Philosophy in Applied Biology and Biochemistry.
501			_00Masters
504			_aIncludes bibliographical references.
650			_aBreast Cancer _xPatients _zZimbabwe.
650			_aBreast Cancer _xChemotherapy _zZimbabwe.
650			_aTamoxifen _xTherapeutic use.
650			_aPharmacogenetics _zZimbabwe.
650			_aPharmacogenetics _zAfrica, Southern.
650			_aPersonalized medicine _zZimbabwe.
650			_aWomen _xHealth and hygiene _zZimbabwe.
700			_aProfessor Collen Masimirembwa. _esupervisor.
700			_aProfessor Andrew Hlanganiso Siwela. _esupervisor.
942			_2lcc _n0 _c3HOUR _hRC278.7.B7 _kRC _mTIZ
999			_c172941 _d172941